An ALK2 inhibitor, BLU-782, prevents heterotopic ossification in a mouse model of fibrodysplasia ossificans progressiva

Post time 2026-6-6 02:54:53

journal：Science Translational Medicine

Authors：Alison J. Davis; Natasja Brooijmans; Jason D. Brubaker; Faith Stevison; Timothy P. LaBranche; Faris Albayya; Paul Fleming; Brian L. Hodous; Joseph L. Kim; Sean Kim; Riadh Lobbardi; Michael Palmer; Michael P. Sheets; John Vassiliadis; Ruduan Wang; Brett D. Williams; Douglas Wilson; Lan Xu; Xing Julia Zhu; Keith Bouchard; Jeffrey W. Hunter; Chris Graul; Elliot Greenblatt; Amira Hussein; Morgan Lyon; Joelle Russo; Rachel Stewart; Marion Dorsch; Timothy J. Guzi; Vivek Kadambi; Christoph Lengauer; Andrew P. Garner

Published date：2024-5-29

DOI：10.1126/scitranslmed.abp8334

PDF link：https://www.science.org/doi/pdf/10.1126/scitranslmed.abp8334

Article link：https://doi.org/10.1126/scitranslmed.abp8334

Article Source：American Association for the Advancement of Science (AAAS)。

Remark：

Post time 2026-6-6 02:54:54

: This post has been completed
Completed attachments will be deleted within 24 hours.

[AAAS] An ALK2 inhibitor, BLU-782, prevents heterotopic ossification in a mouse model of fibrodysplasia ossificans progressiva

Best Answer

Same Category

Latest Reply

Announcement

Daily Top Contributors

[AAAS] An ALK2 inhibitor, BLU-782, prevents heterotopic ossification in a mouse model of fibrodysplasia ossificans progressiva Copy

Best Answer

Same Category

Latest Reply

Announcement

Daily Top Contributors

[AAAS] An ALK2 inhibitor, BLU-782, prevents heterotopic ossification in a mouse model of fibrodysplasia ossificans progressiva